rs61735159
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The ENST00000287538.10(ZIC3):c.861G>A(p.Val287=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00143 in 1,211,024 control chromosomes in the GnomAD database, including 10 homozygotes. There are 478 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0072 ( 4 hom., 216 hem., cov: 25)
Exomes 𝑓: 0.00084 ( 6 hom. 262 hem. )
Consequence
ZIC3
ENST00000287538.10 synonymous
ENST00000287538.10 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.08
Genes affected
ZIC3 (HGNC:12874): (Zic family member 3) This gene encodes a member of the ZIC family of C2H2-type zinc finger proteins. This nuclear protein probably functions as a transcription factor in early stages of left-right body axis formation. Mutations in this gene cause X-linked visceral heterotaxy, which includes congenital heart disease and left-right axis defects in organs. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant X-137567552-G-A is Benign according to our data. Variant chrX-137567552-G-A is described in ClinVar as [Benign]. Clinvar id is 137959.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-137567552-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=1.08 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0072 (812/112805) while in subpopulation AFR AF= 0.0253 (786/31123). AF 95% confidence interval is 0.0238. There are 4 homozygotes in gnomad4. There are 216 alleles in male gnomad4 subpopulation. Median coverage is 25. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 4 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZIC3 | NM_003413.4 | c.861G>A | p.Val287= | synonymous_variant | 1/3 | ENST00000287538.10 | NP_003404.1 | |
ZIC3 | NM_001330661.1 | c.861G>A | p.Val287= | synonymous_variant | 1/3 | NP_001317590.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZIC3 | ENST00000287538.10 | c.861G>A | p.Val287= | synonymous_variant | 1/3 | 1 | NM_003413.4 | ENSP00000287538 | P1 | |
ZIC3 | ENST00000370606.3 | c.861G>A | p.Val287= | synonymous_variant | 1/3 | 5 | ENSP00000359638 |
Frequencies
GnomAD3 genomes AF: 0.00720 AC: 812AN: 112757Hom.: 4 Cov.: 25 AF XY: 0.00619 AC XY: 216AN XY: 34903
GnomAD3 genomes
AF:
AC:
812
AN:
112757
Hom.:
Cov.:
25
AF XY:
AC XY:
216
AN XY:
34903
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00197 AC: 362AN: 183312Hom.: 3 AF XY: 0.00125 AC XY: 85AN XY: 67844
GnomAD3 exomes
AF:
AC:
362
AN:
183312
Hom.:
AF XY:
AC XY:
85
AN XY:
67844
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000840 AC: 923AN: 1098219Hom.: 6 Cov.: 33 AF XY: 0.000721 AC XY: 262AN XY: 363581
GnomAD4 exome
AF:
AC:
923
AN:
1098219
Hom.:
Cov.:
33
AF XY:
AC XY:
262
AN XY:
363581
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00720 AC: 812AN: 112805Hom.: 4 Cov.: 25 AF XY: 0.00618 AC XY: 216AN XY: 34961
GnomAD4 genome
AF:
AC:
812
AN:
112805
Hom.:
Cov.:
25
AF XY:
AC XY:
216
AN XY:
34961
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 23, 2014 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Heterotaxy, visceral, 1, X-linked Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 15, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at